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Background: Several studies show that the consumption of vegetable oils, such as soybean oil, rich in
polyunsaturated fatty acids (PUFAs) has beneficial health effects by preventing or reducing the risk factors of
cardiovascular diseases. While the demonstration of beneficial effects of the consumption of unsaturated fatty acids
on the cardiovascular system has been proven in a macroscopic level, the molecular/cellular mechanisms
responsible for this phenomenon are poorly understood.
Methods: In this work, a comparative proteomic approach, two-dimensional gel electrophoresis (2-DE) coupled to mass
spectrometry (MALDI-TOF/TOF), was applied to investigate proteome differences in the left ventricle (LV) of rats that
received 0.1 mL of soybean oil intramuscularly for 15 days (treated group - TR) and rats that had not (control group - CT).
Results: Soybean oil treatment improved left ventricular function, TR animals presented lower value of LVEDP and
significantly changed LV proteome. The protein profile of VE revealed differences in the expression of 60 protein spots
(p < 0.05) between the experimental groups (CT and TR), 14 of those were identified by MS and MS/MS, and 12 of the 14
being non-redundant proteins. Robust changes were detected in proteins involved in cellular structure and antioxidant
system and muscular contraction.
Conclusions: The TR group presented an increase in the intensity of proteins involved in muscle contraction (myosin
light chain-3 (3-MCL), creatine kinase M (CKM)) and thireodoxin, an antioxidant enzyme. Low intensity cytoskeletal protein,
desmin, was also detected in TR animals. The results suggest that soybean oil induces changes in the levels of heart
proteins which may partially account for the underlying mechanisms involved in the benefits provided by oils rich in
polyunsaturated fatty acids.
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For over 50 years dietary guidelines have recommended
consumption of low saturated fat and high complex car-
bohydrates to reduce the risk of cardiovascular disease.
Despite these recommendations, a greater consumption
of fructose, rapidly absorbed carbohydrates and a lower
intake of complex carbohydrates and fat have been ob-
served in industrialized countries [1,2].
On the other hand, it has been demonstrated that in-
creasing fat intake, which occurs mainly in diets composed
of polyunsaturated fatty acids instead of carbohydrates, is* Correspondence: suelygf@gmail.com
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unless otherwise stated.beneficial in reducing coronary artery disease [2-5]. Dietetic
supplementation with long-chain (C16 and C18) unsaturated
fatty acids (PUFAs) has been shown to decrease insulin re-
sistance, triglyceride levels, heart rate, blood pressure, and
increase HDL cholesterol levels [6]. One important source
of polyunsaturated fatty acids commonly used in industrial-
ized countries is soybean oil. This oil is composed by triac-
ylglycerols with a large proportion of unsaturated fatty
acids, 54,5; 23,2 and 7,2% of linoleic (18:2, Δ9,12), oleic (18:1
Δ9) and linolenic (18:3, Δ9,12,15), respectively.
Linoleic acid has been associated with a reduction of
fatal ventricular fibrillation in mice. A reduction in the
incidence and severity of arrhythmias in ischemia after
adding sunflower seed oil (rich in ω-6); and fish oil (rich
in ω-3) to the diet of rats [7] was demonstrated. Thesel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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unsaturated fatty acids, ω-6 and ω-3, in the diet can re-
duce the likelihood of an ischemic event, avoiding
sudden cardiac death [7].
Recently, Ribeiro Jr. and cols [8] demonstrated that
the treatment of rats with soybean oil improved per-
formance of the left ventricle without affecting blood
pressure, and this was associated with an increase in the
myosin ATPase activity and in the SERCA2a and
sodium-calcium exchanger expression [8].
The purpose of the present study is to apply quantita-
tive and comparative proteomics for the first time in
examination of alterations in the LV proteomic profile of
animals treated with soybean oil. The results may con-
tribute to provide new insight into cellular mechanisms
involved in the benefits provided by soybean oil.
Material and methods
Experimental design and animals
Eight-week old male wistar rats weighing 200-250 g
each, were housed five per cage in a temperature-
controlled environment (22-24°C) with a 12 h/12 h
light–dark cycle and with free access to water and rat
chow ad libitum. All procedures were approved by the
local ethics committee of the Federal University of Espírito
Santo State (protocol n° 052/2013).
The rats were randomized into two groups: control rats
(CT – n = 8) and soybean oil treatment rats (TR – n = 8).
The treated group received a daily dose of 0.1 mL (I.M.) of
soybean oil for 15 days and the control group instead re-
ceived a similar volume of 0.9% NaCl [8].
Hemodynamic measurement
At the end of treatment, rats were weighed and anesthe-
tized with urethane (1.2 g/kg; i.p.). A polyethylene catheter
(PE50) filled with heparinized saline (50 U/mL) was intro-
duced into their carotid artery to measure arterial systolic
blood pressure (SBP) and diastolic blood pressure (DBP).
The carotid artery catheter was introduced into the left
ventricle to measure the systolic pressure (LVSP) and its
positive and negative first derivatives (dP/dt max LV and
dP/dt min LV, respectively), left ventricular end diastolic
pressure (LVEDP), as well as heart rate (HR).
Tissue sampling
After hemodynamic assessment, rats were sacrificed and
their hearts were excised and washed with: Krebs-
Henseleit solution to wash blood (four times); cold sa-
line (three times); and cold Milli-Q water (twice). Then
the atria and surrounding tissues were removed and the
remaining mass of the heart (the ventricles) was sepa-
rated into: left ventricle (LV) and right ventricle (RV).
The tissue corresponding to the left ventricle was weighed
and allocated in cryo tubes, which were immersedimmediately in liquid nitrogen and kept at −80°C until use
for proteomic analysis.
Sample preparation
Four samples of LV from each experimental group were
selected for randomized analysis, processed separately
and used for the 2-DE gel analysis. LV protein extrac-
tion was performed as previously described [9] with
some modifications. LV portions were pulverized in li-
quid nitrogen, then a portion (≅250 mg) of powdered
LV was homogenized by an ultrasonic sonicator (XL-
2000, QSonica) on ice in 10 volumes of two-
dimensional lysis buffer (8 M urea, 2 M thiourea, 4%
CHAPS, 40 mM Tris base and 0,2% protease inhibitor
cocktail - Sigma-Aldrich). Then the homogenates were
centrifuged (12.000 g for 45 min at 4°C) and the super-
natants were collected and assayed for protein quantifi-
cation (2-D Quant Kit – GE Healthcare). Aliquots of
the protein extracts were separated into single-use sam-
ples and stored at −80°C until use.
Two-dimensional gel electrophoresis (2-DE)
For the first dimension (isoelectric focusing), aliquots of
800 μg of LV soluble protein were diluted to a final vol-
ume of 350 μL in a rehydration buffer (Destreak, GE
Healthcare) supplemented with 0.2% ampholytes pH 3–
10. Samples were applied to the Immobiline DryStrips
(17 cm; pH 3–10 NL; GE Healthcare) by gel rehydration.
All isoelectric focusing was performed on a Protean IEF
cell system (Bio-Rad) at a temperature of 20°C and a
maximum current of 50 mA/strip. Focusing parameters
were as follow: active rehydration (50 V) for 30 h; step 1
(300 V) for 3 h; step 2 (4.000 V) for 2 h; step 3 (4.000 V
until complete 20.000Vh); step 4 (500 V) for 2 h. After
the first-dimensional run, the IGP gel strip was incu-
bated for 15 minutes in an equilibration buffer (50 mM
Tris–HCl, pH 8.8; 6 M urea, 30% glycerol, 2% SDS,
traces of bromophenol blue) containing 10 mg/mL di-
thiothreitol, followed by a second incubation in the same
equilibration buffer containing 25 mg/mL iodoacetamide
for 15 min. Then the IGP strips were sealed using 0.5%
agarose in standard Tris-Glycine-SDS electrophoresis
buffer. The second dimension electrophoresis was per-
formed with 12.5% polyacrylamide gels [10] in Ettan
DALTsix eletrophoresis unit (GE Healthcare life sciences)
at 40 mA/gel until the dye front reached the bottom of
the gel at 15°C. Gels were stained with colloidal Coo-
massie Blue Brilliant G-250, [11].
2-DE image analysis
Gel images were documented using an ImageScanner III
calibrated densitometer (GE Healthcare). Eight two di-
mensional gels were obtained, four independent samples
(4 biological replicates) per group. Data from 2-DE gels
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ware 7.05 (GE Healthcare). The authenticity and outline
of each spot were validated by visual inspection and edi-
ted when necessary. The intensity of each protein spot
was normalized relative to the total abundance of all
valid spots. Spots that exhibited significant differences
between the groups (CT and TR) were selected for pro-
tein identification by mass spectrometry. Significance of
differences observed was determined by the analysis of
variance (ANOVA), and α < 0.05 was adopted as the
level of significance.
Identification of spots by mass spectrometry
Protein spots with differential intensity were manually
excised from the gel. Gel pieces were then distained by
rinsing three times of 15 minutes with 50% acetonitrile
in 25 mM ammonium bicarbonate, followed by pure
acetonitrile washing for five minutes, after being dried
by SpeedVac (Eppendorf ). Dried gel fragments were then
rehydrated with 10 μL of protease solution (Trypsin
Gold, Mass Spectrometry Grade, Promega, at 20 ng/μL
in 50 mM ammonium bicarbonate) for 30 min in ice,
then 20 μL of 50 mM ammonium bicarbonate was
added and digestion was carried out for 16 h at 37°C.
The peptides formed by digestion were extracted from
the gel by washing twice, over constant shaking for
30 minutes each, with 30 μL of 50% acetonitrile/5% for-
mic acid. Trypsin digests were concentrated in a Speed-
Vac (Eppendorf ) to about 10 μL. The protein digests
were subjected to a desalting step using Zip-Tip (C18
resin; P10, Millipore) as previously reported [12].
The tryptic peptides were analysed with a MALDI-
TOF–TOF AB Sciex 5800 (AB Sciex, Foster City, CA)
mass spectrometer. MS and MS/MS spectra were ac-
quired in reflector mode to ensure optimal mass accur-
acy and peak resolution. Usually up to 15 of the most
intense ion signals with signal to noise ratios above 2
were selected as precursors for MS/MS acquisition. Dur-
ing this data dependent analysis, an exclusion list with
common trypsin autolysis masses and keratine masses
was applied. External calibration in MS mode was per-
formed using a mixture of five peptides: des-Arg1-
Bradykinin (m/z = 904.468), angiotensin I (m/z =
1296.685), Glu1-fibrinopeptide B (m/z = 1570.677), and
ACTH (18–39 clip) (m/z = 2465.199), and ACTH (7–38
clip) (m/z = 3657.929). Similarly, tandem mass spectra
were externally calibrated using known fragment ion
masses observed in the MS/MS spectrum of Glu1-
fibrinopeptide B.
MS and MS/MS spectra were combined by BioTools
(BrukerDaltonics) and used for search against the NCBI
nonredundant database using the MASCOT® software
(http://www.matrixscience.com). Search parameters were
as follows: no restrictions on protein molecular weight;Rattus taxonomic; only tryptic peptides with one
missed cleavage were considered; fixed and variable
modifications were carbamidomethylation of Cys resi-
dues and Met-oxidation, respectively; mass accuracy of
0.8 Da were acceptable for matching peptides (MS and
MS/MS mode).
Gel fragments with no protein and gel fragments from
the molecular weight standard (bovine albumin) were
used as negative and positive controls, respectively. Pro-
tein identified by homology with Rattus novergicus spe-
cies, and with a global Mascot score with α < 0.05 was
considered significant. Biological processes categorization
was based upon information provided by Gene Ontology
(GO); PANTHER [13] and UniProt’s database classifica-
tion system (for Rattus norvegicus).
Statistical analysis
Results are presented as mean ± SEM. Values were ana-
lysed by GraphPad Prism version 5.0 using an unpaired
Student’s t-test, α < 0.05 was adopted as the level of
significance.
Results
General characteristics and cardiac hemodynamic
At the end of the treatment, the body weight of animals
treated with soybean oil was similar to the body weight
of animals in the control group (CT: 310 ± 11.6 vs. TR:
301 ± 9.28 g). Soybean oil treatment did not cause sig-
nificant alterations in the left ventricle to body weight
ratio compared to controls (CT: 0.62 ± 0.04 vs. TR:
0.71 ± 0.04 mg/g), suggesting that ventricular hyper-
trophy did not occur.
No significant differences were found in heart rate,
systolic blood pressure, diastolic blood pressure, left ven-
tricular systolic pressure, maximal rate of pressure devel-
opment; or maximal rate of pressure decay between
groups (Table 1). However the TR animals showed a
lower LVEDP (29.2%) when compared to controls.
Comparative proteome analysis of the left ventricle of
animals control and treated with soybean oil
In order to evaluate the effect of soybean oil on proteins
of LV, a total of eight (four per group) large format 2-DE
gels were obtained, and used for differential proteome
analysis. An outline of the gel figures are shown in the
Additional file 1. The Factor analysis already suggests
differences in the protein profile of the left ventricle in
the CT and the TR groups. An outline of the factor ana-
lysis is shown in the Additional file 2. The Coomassie
blue staining spot pattern was observed to be compar-
able between groups.
The image analysis of 2-DE gels detected an average of
401 spots for the CT group and 367 for the TR group.
The 2-DE protein profiles obtained from CT and TR
Table 1 Hemodynamic measures from control (CT) and
soybean oil-treated rats (TR)
CT (n = 8) TR (n = 8)
HR, bpm 374 ± 18 342 ± 14
SBP, mmHg 114.9 ± 4.6 102.57 ± 4.88
DBP, mmHg 81.6 ± 5.9 73.75 ± 5.44
PAM, mmHg 98.8 ± 4.9 82.5 ± 6.08
LVSP, mmHg 128.4 ± 6.6 118.8 ± 5.07
LVEDP, mmHg 6.08 ± 0.41 4.31 ± 0.26*
dP/dt+, mmHg/s 6656. ± 691 6066 ± 434
dP/dt -, mmHg/s 8061 ± 397 6994 ± 414
HR - heart rate; SBP - systolic blood pressure; DBP - diastolic blood pressure;
LVSP left ventricle systolic pressure; LVEDP - left ventricle end diastolic pressure;
dP/dt +maximal rate of pressure development; dP/dt − maximal rate of pressure
decay. Data are mean ± S.E.M. Student “t” test, *p < 0.05 vs. CT.
Figure 1 Representative 2-DE protein extracts of the left ventricle of the an
different (p <0.05) between groups. (°) spots only visualized in the gels of t
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ber of protein spots, intensities and relative positions
within the same group (correlation coefficient >0.94).
Analysis was performed by the Image Master 2D Platinun
v 7.05 software analysis and indicated that 60 proteins spots
was significantly different (p < 0.05) between CT and TR
group. Out of the 60 spots 39 (65%) were down-regulated,
and 21 (35%) were up-regulated in the TR group compared
to the CT group. A representative CT 2-DE gel is shown in
Figure 1, in which numbers indicate significantly different
spots between analyzed groups.Protein identification of differentially expressed protein
spots
Of the 60 differentially expressed protein spots, 39 were
removed from the gels and processed for analysis by
mass spectrometry system for MALDI/TOF-TOF.animal CT. The numbered and surrounded points are statistically
he TR group. (*) proteins identified by MS and MS/MS.
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guishable to the naked eye, therefore were not used
for analysis in MALDI/TOF-TOF. Protein identifica-
tion by MS/MS was successfully obtained for 14 spots.
The same gene product was identified in two different
spots, indicating potential diversity of protein forms
including post-translational modifications (PTMs),
mutations and/or isoforms. Thus, the 14 identified gel
spots comprise 12 gene products that were differen-
tially expressed between CT and TR left ventricular
tissue. Proteins identified are indicated in Figure 1 by
asterisk and listed in Table 2.
The identified proteins fell into several functional cat-
egories and subcellular localization. The classification of
these proteins using the subcellular localization database
revealed that the differentially expressed proteins com-
prised cytoplasmic, mitochondrial, cytoskeletal and
myosin-complex related proteins. GO- and UniProt-based
biological process categorisation showed these proteins to
be involved in muscle contraction and cellular structure,
energy production (lipids, carbohydrates metabolism and
proteins of electron transport chain of oxidative phos-
phorylation) and antioxidant proteins. Notably, the TR
group showed up-regulation of contractile proteins, such
as the myosin light chain-3 and creatine kinase M-type
and antioxidants, such as thioredoxin. Structural proteins,
as desmin, showed downregulation.
Discussion
An increasing amount of data seems to imply that poly-
unsaturated fatty acids are important in cardiovascular
disease risk reduction both in the general population
and in patients with preexisting heart disease. Evidence
shows that supplementation with ω-3 at doses >3 g/day
can lessen cardiovascular disease risk factors, including
plasma triacylglycerols, blood pressure, platelet aggre-
gation, and inflammation, while improving vascular
reactivity [14].
The left ventricular isovolumetric systolic pressure and
inotropic response to extracellular Ca2+ and iso-
proterenol were higher in the soybean-treated animals
than in the control group. These changes were associ-
ated with increased myosin ATPase activity and alter-
ations in calcium handling proteins, which are related to
positive inotropism and regulation and maintenance of
sarcoplasmic reticulum calcium load [15,16].
Considering that vegetable oils could promote cardiac
benefits by inducing changes in the heart proteins levels.
In the present study a proteomic approach was used to
demonstrate the differences between the CT group LV
proteome profile and the TR group with soybean oil
injected intramuscularly for 15 days LV proteome pro-
file. Tissue samples were analyzed by 2-DE-MS/MS and
resulted in the identification of proteins that may beinvolved in the significant improvement of ventricular
function after the soybean treatment.
Proteome comparison between CT and TR identified 60
intensity changes in protein spots, 14 (23.3%) of which
were identified by MS/MS and account for 12 non-
redundant proteins. The protein changes identified could
be categorized into 6 classes, using GO- and UniProt-
base, according to their functional significance: (i) proteins
of cardiac muscle contraction: myosin light chain-3
(MCL-3); creatine kinase M-type (CKMM); (ii) energy
metabolism: NADH dehydrogenase, glycogen phosphoryl-
ase, long-chain-fatty-acid-CoA ligase 1; (iii) Structural:
desmin; (iv) stress: bc1 chaperone, thioredoxin, prepro-
haptoglobin; (v) protein membrane: Vdac 1; (vi) of protein
biosynthesis: elongation factor Tu.
Myosin light chain proteins are essential components
in the generation of actin-based contractile force. As re-
ported by our analysis, two protein spots (1 and 4) cor-
responding to myosin light chain-3 were up-regulated
1.33 and 3.24 fold respectively in the treated group. This
data is in accordance with several studies that demon-
strate that lowering the expression of myosin is associ-
ated with contractile dysfunction observed in dilated
cardiomyopathy [17] and heart failure [18].
In addition we observed a large decrease of desmin, a
muscle-specific intermediate filament protein type III, in
the TR animals. This result is consonant with numerous in-
dependent studies that demonstrate involvement of desmin
in human and experimental animal cardiac diseases com-
prehending accumulation of desmin deposits [19].
Faber and employees, performing a proteomic analysis
of the RV of rats presenting pathological hypertrophy,
observed increased desmin expression in this scenario
[20]. Another study involving human hearts suffering
from congestive heart failure identified, by western blot,
an increase of desmin protein expression [19]. Also, in-
creases in the protein expression level of this intermedi-
ate filament have also been observed in a hypertrophic
cardiomyopathy (HCM) mouse model [21]. It was sug-
gested that desmin overexpression in HCM mice is a
compensatory or adaptive response to cell integrity loss
in an attempt to reinforce the contractile units of the
myocyte, thereby enhancing contractility [20]. Desmin
has proven to be a sensitive biomarker for evaluating
the deterioration degree of myocardial infarction [22]
and it was designated as an intracellular marker for
heart failure [23,24]. We speculate that both the in-
crease in intensity of myosin light chain-3 and the de-
crease in desmin levels may be associated with the
improved cardiac function observed in the oil treated
group.
Moreover, pronounced changes in creatine kinase
type M (CK-M), which belongs to the category of car-
diac muscle contraction proteins, was observed in this
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intracellular enzyme that provides temporal and
spatial energy buffering. It catalyses the reversible
transfer of a phosphate moiety between creatine and
ATP and it plays a central role in supplying energy to
several tissues, such as skeletal muscle tissue and
heart tissue. CK deficiency is a hallmark of cardiovas-
cular diseases [25], suggesting that it is essential to
myocardial energy homeostasis. Spindler and cols.
showed that creatine kinase-deficient hearts exhibit
increased susceptibility to ischemia-reperfusion injury
and impaired calcium homeostasis [26].
In this work CK-M was identified in two distinct pro-
tein spots (2 and 8). It may be suggested that the acid
form is phosphorylated and hence a post-translational
modification of the basic form (PTM). However, an im-
balance was found in the intensity levels of these spots.
The CK more basic form (spot 2) and its less basic form
(spot 8) exhibited higher and lower intensity in the
treated group, repectively. Despite this imbalance, there
is an increase in absolute abundance of this enzyme in
treated oil animals (1.27 fold). Because a proportion of
M type-CK is associated with sites of excitation-
contraction coupling providing energy for contractility
and SR-Ca2+ reuptake [27,28], the over-regulation of CK,
found in treated animals in this work, may be one pos-
sible explanation for the improved performance of the
LV induced by unsaturated oils, which is consistent with
cardioprotection afforded by unsaturated oils.
A large body of research has suggested that highly
reactive oxygen derived free radicals (ROS) of en-
dogenous or environmental origin play a cognitive
role in the genesis and progression of various CVDs
[29,30]. In this work, expression pattern modification
in two antioxidant enzymes was found. There was an
increased intensity of the two in the treated group.Thioredoxin - Trx (1.68 fold) and haptoglobin - Hp
were identified only in the TR group. Txr protects
radical-sensitive enzymes from oxidative damage using
a radical-generating system. It acts synergistically with
MAP3K13 to regulate the activation of NF-kappa-B in
the cytosol. Haptoglobin also acts as an acute phase
protein and has been associated with a variety of
common disorders (e.g. cardiovascular disease, auto-
immune disorders, malignancy) [31].
In agreement with our findings, the plasma low levels
of Hp have been associated with a worse functional out-
come after myocardial infarction [32]. In addition, Tun-
cay and colleagues [33] suggested the intake of ω-3 has
an important beneficial effect in the protection of
diabetes-induced cardiac dysfunction. They also showed
the levels of Trx reductase and other enzymes that ex-
hibit antioxidant activities decrease in the diabetic heart,
a situation that was normalized after treatment with
omega-3, similar to the results in this study.
Although previous studies have reported the over ex-
pression of calcium handling proteins (sodium-calcium
exchange - NCX and SERCA2a) [8], we have not identi-
fied ion transport proteins in this study, with the excep-
tion of the Vdac I (more abundant in CT group). Vdac
forms a channel through the mitochondrial outer mem-
brane and also through the plasma membrane.
Besides its ion transport and porine functions, Vdac
has also been shown to play a role in the apoptotic
process [34] and a key role in regulating metabolic and
energetic flux across the outer mitochondrial membrane.
The speculative higher levels of Vdac in the CT group
seem consistent with the key role the molecule has in
coupling glycolysis to oxidative phosphorylation [35] this
could also be associated with the higher levels of glico-
gen phosphorylase in CT animals. On the other hand,
we cannot associate the other differentially expressed
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soybean oil.
Despite the advantages of applying quantitative prote-
omics to examine the effects of soybean oil on LV rats
proteome, there are limitations that must be considered,
(i) low protein resolution in the gel basic area, (ii) the
protein extraction method was not efficient for mem-
brane proteins; (iii) identification of only 23.3% of pro-
tein spots with differences in intensity. A more sensitive
method (e.g. Ettan DIGE) could be used for great prote-
omic hits.
In conclusion, we have demonstrated for the first time
that soybean oil induces alterations in the rats’ LV prote-
ome. Our study revealed that alterations in the expres-
sion level of proteins involved in muscle contraction,
cellular structure and antioxidant system in LV treated
animals can be correlated with improvement in left ven-
tricular performance. These data corroborate the under-
standing of the mechanisms involved in cardioprotection
afforded by this specific oil.
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